In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $74.77 in the prior trading day, GE HealthCare Technologies Inc (NASDAQ: GEHC) closed at $74.6, down -0.23%. In other words, the price has decreased by -$0.23 from its previous closing price. On the day, 3.03 million shares were traded. GEHC stock price reached its highest trading level at $75.44 during the session, while it also had its lowest trading level at $74.47.
Ratios:
Our goal is to gain a better understanding of GEHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.76. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.88.
On March 11, 2025, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $85 to $100. Jefferies Upgraded its Hold to Buy on January 08, 2025, whereas the target price for the stock was revised from $95 to $103.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 22 ’25 when Kenneth Stacherski bought 19,524 shares for $74.46 per share.
Kenneth Stacherski bought 11,757 shares of GEHC for $905,590 on Sep 12 ’25. On Feb 18 ’25, another insider, Newcomb George A., who serves as the Chief Accounting Officer of the company, sold 2,000 shares for $92.54 each. As a result, the insider received 185,080 and left with 7,462 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 34059528192 and an Enterprise Value of 41279528960. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.27, and their Forward P/E ratio for the next fiscal year is 15.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71 while its Price-to-Book (P/B) ratio in mrq is 3.51. Its current Enterprise Value per Revenue stands at 2.067 whereas that against EBITDA is 11.236.
Stock Price History:
The Beta on a monthly basis for GEHC is 1.27, which has changed by -0.1979357 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, GEHC has reached a high of $94.80, while it has fallen to a 52-week low of $57.65. The 50-Day Moving Average of the stock is 0.06%, while the 200-Day Moving Average is calculated to be -3.14%.
Shares Statistics:
The stock has traded on average 3.78M shares per day over the past 3-months and 3780330 shares per day over the last 10 days, according to various share statistics. A total of 456.56M shares are outstanding, with a floating share count of 455.29M. Insiders hold about 0.28% of the company’s shares, while institutions hold 84.73% stake in the company. Shares short for GEHC as of 1756425600 were 7357594 with a Short Ratio of 1.95, compared to 1753920000 on 9024652. Therefore, it implies a Short% of Shares Outstanding of 7357594 and a Short% of Float of 2.1300000999999997.
Earnings Estimates
Investors are keenly observing as 15.0 analysts analyze and rate the current performance of GE HealthCare Technologies Inc (GEHC) in the stock market.The consensus estimate for the next quarter is $1.38, with high estimates of $1.43 and low estimates of $1.2.
Analysts are recommending an EPS of between $4.55 and $3.97 for the fiscal current year, implying an average EPS of $4.48. EPS for the following year is $4.86, with 20.0 analysts recommending between $5.13 and $4.05.
Revenue Estimates
13 analysts predict $5.07B in revenue for the current quarter. It ranges from a high estimate of $5.11B to a low estimate of $5.01B. As of the current estimate, GE HealthCare Technologies Inc’s year-ago sales were $4.86BFor the next quarter, 13 analysts are estimating revenue of $5.61B. There is a high estimate of $5.68B for the next quarter, whereas the lowest estimate is $5.53B.
A total of 19 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.58B, while the lowest revenue estimate was $20.08B, resulting in an average revenue estimate of $20.43B. In the same quarter a year ago, actual revenue was $19.67BBased on 19 analysts’ estimates, the company’s revenue will be $21.37B in the next fiscal year. The high estimate is $21.71B and the low estimate is $20.78B.
